Medscape Medical NewsAll articles

JLK-SDH

JLK, Inc. • Radiology • 03/03/2025

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The JLK-SDH is a radiological computer-aided triage and notification software that employs an artificial intelligence algorithm to identify suspected subdural hemorrhage from non-contrast head CT images, intended to assist trained radiologists. This device's methodology involves analyzing imaging data for SDH indicators and sending high-accuracy notifications, underpinned by performance validation demonstrating 97.1% sensitivity and 97.4% specificity, confirming its scientific utility as a clinical communication aid.

Summary

JLK, Inc.'s JLK-SDH is a radiological computer-aided triage and notification software designed to assist trained radiologists in identifying and communicating suspected subdural hemorrhage (SDH) from non-contrast CT images of the head. This device operates as a notification-only, parallel workflow tool, employing an artificial intelligence algorithm to analyze images and alert appropriate users. It has been determined to be substantially equivalent to a legally marketed predicate device for its intended use. The JLK-SDH system analyzes imaging data for findings suggestive of SDH and sends notifications to clinicians, recommending a review of the identified images. While it is a notification tool and not for diagnostic use, performance validation testing showed high accuracy, achieving 97.1% sensitivity and 97.4% specificity in detecting SDH across diverse patient demographics and scanner manufacturers. The system also demonstrated efficient notification times, underscoring its effectiveness as a triage and communication aid in clinical settings.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

JLK-SDHSubdural hemorrhageCT imagesArtificial intelligenceRadiologyTriage softwareNotification systemSensitivitySpecificityClinical workflow

Device Metadata

Submission Number
K243611
Company
JLK, Inc.
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. What specific features or patterns does the AI algorithm prioritize to achieve its high sensitivity and specificity in detecting SDH, and how does it differentiate from other intracranial pathologies?; How does the JLK-SDH system integrate into existing Picture Archiving and Communication Systems (PACS) and Hospital Information Systems (HIS), and what are the practical implications for seamless clinical adoption?; Beyond the stated sensitivity and specificity, what was the clinical impact of the system on patient management, such as reduction in turnaround time or improved patient outcomes?; Has the JLK-SDH been validated on diverse datasets representing different scanner models, image acquisition protocols, or patient populations, particularly those with subtle or atypical presentations of SDH?; What are the known limitations or potential failure modes of the AI algorithm, such as false positives or false negatives, and under what circumstances are these more likely to occur?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score5/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
JLK-SDH - JLK, Inc. | ESL FDA AI Device Intelligence